vs

Side-by-side financial comparison of Claros Mortgage Trust, Inc. (CMTG) and PRECISION BIOSCIENCES INC (DTIL). Click either name above to swap in a different company.

Claros Mortgage Trust, Inc. is the larger business by last-quarter revenue ($46.7M vs $34.2M, roughly 1.4× PRECISION BIOSCIENCES INC). PRECISION BIOSCIENCES INC runs the higher net margin — 58.9% vs -468.9%, a 527.8% gap on every dollar of revenue. On growth, PRECISION BIOSCIENCES INC posted the faster year-over-year revenue change (5261.1% vs -22.4%). Over the past eight quarters, PRECISION BIOSCIENCES INC's revenue compounded faster (39.5% CAGR vs -10.9%).

Claros Mortgage Trust, Inc. is a U.S.-based real estate investment trust that invests in diversified mortgage-related assets, including residential and commercial mortgage loans and mortgage-backed securities. It pursues stable, risk-adjusted long-term returns for shareholders via rigorous asset evaluation and active portfolio management.

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.

CMTG vs DTIL — Head-to-Head

Bigger by revenue
CMTG
CMTG
1.4× larger
CMTG
$46.7M
$34.2M
DTIL
Growing faster (revenue YoY)
DTIL
DTIL
+5283.5% gap
DTIL
5261.1%
-22.4%
CMTG
Higher net margin
DTIL
DTIL
527.8% more per $
DTIL
58.9%
-468.9%
CMTG
Faster 2-yr revenue CAGR
DTIL
DTIL
Annualised
DTIL
39.5%
-10.9%
CMTG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CMTG
CMTG
DTIL
DTIL
Revenue
$46.7M
$34.2M
Net Profit
$-219.2M
$20.1M
Gross Margin
Operating Margin
36.6%
Net Margin
-468.9%
58.9%
Revenue YoY
-22.4%
5261.1%
Net Profit YoY
-117.7%
213.5%
EPS (diluted)
$-1.56
$2.62

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMTG
CMTG
DTIL
DTIL
Q4 25
$46.7M
$34.2M
Q3 25
$46.1M
$13.0K
Q2 25
$51.6M
$18.0K
Q1 25
$43.4M
$29.0K
Q4 24
$60.2M
$638.0K
Q3 24
$64.9M
$576.0K
Q2 24
$64.5M
$49.9M
Q1 24
$58.8M
$17.6M
Net Profit
CMTG
CMTG
DTIL
DTIL
Q4 25
$-219.2M
$20.1M
Q3 25
$-9.5M
$-21.8M
Q2 25
$-181.7M
$-23.5M
Q1 25
$-78.6M
$-20.6M
Q4 24
$-100.7M
Q3 24
$-56.2M
$-16.4M
Q2 24
$-11.6M
$32.7M
Q1 24
$-52.8M
$8.6M
Operating Margin
CMTG
CMTG
DTIL
DTIL
Q4 25
36.6%
Q3 25
-158976.9%
Q2 25
-121538.9%
Q1 25
-76248.3%
Q4 24
Q3 24
-3693.6%
Q2 24
48.4%
Q1 24
-23.8%
Net Margin
CMTG
CMTG
DTIL
DTIL
Q4 25
-468.9%
58.9%
Q3 25
-20.7%
-167476.9%
Q2 25
-351.9%
-130666.7%
Q1 25
-181.3%
-70913.8%
Q4 24
-167.2%
Q3 24
-86.7%
-2851.6%
Q2 24
-17.9%
65.6%
Q1 24
-89.7%
48.8%
EPS (diluted)
CMTG
CMTG
DTIL
DTIL
Q4 25
$-1.56
$2.62
Q3 25
$-0.07
$-1.84
Q2 25
$-1.30
$-2.13
Q1 25
$-0.56
$-2.21
Q4 24
$-0.72
Q3 24
$-0.40
$-2.25
Q2 24
$-0.09
$4.67
Q1 24
$-0.39
$1.70

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMTG
CMTG
DTIL
DTIL
Cash + ST InvestmentsLiquidity on hand
$173.2M
$115.6M
Total DebtLower is stronger
$3.2B
Stockholders' EquityBook value
$1.5B
$92.2M
Total Assets
$4.7B
$154.4M
Debt / EquityLower = less leverage
2.06×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMTG
CMTG
DTIL
DTIL
Q4 25
$173.2M
$115.6M
Q3 25
$339.5M
$44.9M
Q2 25
$209.2M
$62.2M
Q1 25
$127.8M
$77.2M
Q4 24
$99.1M
$86.3M
Q3 24
$113.9M
$101.2M
Q2 24
$148.2M
$123.6M
Q1 24
$232.5M
$137.8M
Total Debt
CMTG
CMTG
DTIL
DTIL
Q4 25
$3.2B
Q3 25
$3.7B
Q2 25
$4.0B
Q1 25
$4.7B
Q4 24
$4.9B
Q3 24
$5.1B
Q2 24
$5.3B
Q1 24
$5.5B
Stockholders' Equity
CMTG
CMTG
DTIL
DTIL
Q4 25
$1.5B
$92.2M
Q3 25
$1.7B
$16.6M
Q2 25
$1.8B
$34.1M
Q1 25
$1.9B
$49.3M
Q4 24
$2.0B
$56.4M
Q3 24
$2.1B
$64.9M
Q2 24
$2.2B
$74.7M
Q1 24
$2.2B
$37.2M
Total Assets
CMTG
CMTG
DTIL
DTIL
Q4 25
$4.7B
$154.4M
Q3 25
$5.4B
$93.5M
Q2 25
$5.8B
$108.9M
Q1 25
$6.7B
$124.4M
Q4 24
$7.0B
$136.4M
Q3 24
$7.3B
$153.3M
Q2 24
$7.6B
$165.8M
Q1 24
$7.8B
$184.7M
Debt / Equity
CMTG
CMTG
DTIL
DTIL
Q4 25
2.06×
Q3 25
2.09×
Q2 25
2.29×
Q1 25
2.42×
Q4 24
2.44×
Q3 24
2.44×
Q2 24
2.46×
Q1 24
2.47×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMTG
CMTG
DTIL
DTIL
Operating Cash FlowLast quarter
$-30.5M
$-11.3M
Free Cash FlowOCF − Capex
$-11.3M
FCF MarginFCF / Revenue
-32.9%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
-0.56×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMTG
CMTG
DTIL
DTIL
Q4 25
$-30.5M
$-11.3M
Q3 25
$8.8M
$-15.3M
Q2 25
$-5.8M
$-20.3M
Q1 25
$-35.8M
$-19.1M
Q4 24
$84.5M
$-58.4M
Q3 24
$39.2M
$-5.9M
Q2 24
$5.5M
$-14.9M
Q1 24
$21.5M
$-19.0M
Free Cash Flow
CMTG
CMTG
DTIL
DTIL
Q4 25
$-11.3M
Q3 25
Q2 25
$-20.3M
Q1 25
$-19.1M
Q4 24
$-58.7M
Q3 24
$-6.0M
Q2 24
$-14.9M
Q1 24
$-19.1M
FCF Margin
CMTG
CMTG
DTIL
DTIL
Q4 25
-32.9%
Q3 25
Q2 25
-112627.8%
Q1 25
-65917.2%
Q4 24
-9199.8%
Q3 24
-1033.2%
Q2 24
-29.9%
Q1 24
-108.4%
Capex Intensity
CMTG
CMTG
DTIL
DTIL
Q4 25
0.1%
Q3 25
0.0%
Q2 25
11.1%
Q1 25
220.7%
Q4 24
39.2%
Q3 24
6.8%
Q2 24
0.1%
Q1 24
0.5%
Cash Conversion
CMTG
CMTG
DTIL
DTIL
Q4 25
-0.56×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-0.45×
Q1 24
-2.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CMTG
CMTG

Real Estate Owned Portfolio$34.2M73%
Other$11.1M24%
Mixed Use Property Fixed Rents$1.4M3%

DTIL
DTIL

Segment breakdown not available.

Related Comparisons